Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.240
-0.020 (-1.59%)
Nov 21, 2024, 4:00 PM EST - Market closed
Century Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -129.89 | -136.67 | -130.93 | -95.82 | -53.58 | -244.77 |
| Depreciation & Amortization | 13.54 | 13.04 | 8.44 | 3.75 | 1.4 | 0.25 |
| Other Amortization | - | 0.09 | 0.3 | 0.31 | 0.09 | - |
| Asset Writedown & Restructuring Costs | 12.15 | 16.37 | - | - | 4.72 | 225.95 |
| Loss (Gain) From Sale of Investments | -7.76 | -3.98 | - | - | - | - |
| Stock-Based Compensation | 13.59 | 14.62 | 10.67 | 4.73 | 0.88 | 0.15 |
| Other Operating Activities | -0.7 | -1.2 | 1.63 | 0.83 | 0.35 | - |
| Change in Accounts Payable | -4.83 | -2.36 | -4.79 | -1.85 | 2.06 | 1.23 |
| Change in Unearned Revenue | -2.68 | -2.24 | 117.99 | - | - | - |
| Change in Other Net Operating Assets | -5.54 | 13.98 | 10.75 | -0.95 | 2.8 | 1.03 |
| Operating Cash Flow | -112.14 | -88.35 | 14.05 | -89 | -41.27 | -16.17 |
| Capital Expenditures | -0.98 | -13.74 | -30.6 | -44.97 | -9.83 | -2.46 |
| Cash Acquisitions | -9.61 | - | - | - | -4.72 | 24.17 |
| Investment in Securities | 46.05 | 74.87 | 17.48 | -253.37 | -8.21 | -41.54 |
| Investing Cash Flow | 35.48 | 61.13 | -13.13 | -298.34 | -22.76 | -19.83 |
| Long-Term Debt Issued | - | - | - | - | 9.73 | - |
| Long-Term Debt Repaid | - | -10.24 | - | - | - | - |
| Net Debt Issued (Repaid) | - | -10.24 | - | - | 9.73 | - |
| Issuance of Common Stock | 74.81 | 0.52 | 27.16 | 277.07 | 38.1 | 75 |
| Other Financing Activities | - | - | - | -18.92 | -0.14 | -0.16 |
| Financing Cash Flow | 74.81 | -9.73 | 27.16 | 417.77 | 47.69 | 74.84 |
| Net Cash Flow | -1.85 | -36.94 | 28.08 | 30.43 | -16.34 | 38.84 |
| Free Cash Flow | -113.12 | -102.08 | -16.55 | -133.97 | -51.09 | -18.63 |
| Free Cash Flow Margin | -4214.68% | -4567.52% | -318.37% | - | - | - |
| Free Cash Flow Per Share | -1.56 | -1.72 | -0.29 | -4.14 | -6.83 | -2.75 |
| Cash Interest Paid | - | 0.59 | 1.1 | 0.97 | 0.21 | - |
| Cash Income Tax Paid | 1.62 | 2.52 | - | 0.01 | - | - |
| Levered Free Cash Flow | -62.05 | -71.09 | -79.59 | -96.45 | -30.01 | - |
| Unlevered Free Cash Flow | -62.05 | -70.85 | -79 | -95.96 | -29.87 | - |
| Change in Net Working Capital | 6.03 | 6.54 | -9.89 | 0.1 | -8.42 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.